Rockwell Medical reports Q1 adjusted EPS (1c) vs. (1c) last year

Reports Q1 revenue $17.3M vs. $18.9M last year. “Our financial and operational performance in the first quarter 2026 builds on the positive trajectory we have established across our key financial metrics, which we expect to continue throughout the remainder of the year,” said Mark Strobeck, CEO. “By streamlining our operations, we are on track to generate meaningful cost savings that we believe will support sustained profitability. Our 2026 guidance is centered around strengthening revenue, expanding gross margin, and generating positive Adjusted EBITDA and cash flow.”